Subject
Pharmacology,Immunology,Immunology and Allergy
Reference48 articles.
1. B.D. Fleming, D.J. Urban, M.D. Hall, T. Longerich, T.F. Greten, I. Pastan, M. Ho, Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention, Hepatology (Baltimore, Md.) 71(5) (2020) 1696-1711.
2. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches;Sapisochin;Nat. Rev. Gastroenterol. Hepatol.,2017
3. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence;Vivarelli;Ann. Surg.,2008
4. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression;Vivarelli;Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,2005
5. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma;Grigg;Aliment. Pharmacol. Ther.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献